Rankings
▼
Calendar
RGEN FY 2021 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
FY 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$671M
+83.1% YoY
Gross Profit
$391M
58.3% margin
Operating Income
$167M
24.9% margin
Net Income
$128M
19.1% margin
EPS (Diluted)
$2.24
Cash Flow
Operating Cash Flow
$119M
Free Cash Flow
$48M
Stock-Based Comp.
$28M
Balance Sheet
Total Assets
$2.4B
Total Liabilities
$608M
Stockholders' Equity
$1.8B
Cash & Equivalents
$604M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$671M
$366M
+83.1%
Gross Profit
$391M
$194M
+101.3%
Operating Income
$167M
$81M
+105.7%
Net Income
$128M
$60M
+114.1%
← Q4 2020
All Quarters
Q1 2021 →